ACLARIS THERAPEUTICS INC (ACRS) Institutional Ownership

ACRS is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $1.88M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $1.88M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's ACRS position is now estimated to be worth approximately $2.22M, representing an estimated gain of +17.87% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional holding trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward ACLARIS THERAPEUTICS INC (ACRS).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20261$1,884,866502,631
Q4 20251$3,387,2461,125,331
Q3 20251$3,077,4891,619,731
Q2 20251$2,079,9851,464,778
Q1 20251$1,455,633951,394
Q4 20241$2,109,287850,519
Q3 20241$1,576,3051,370,700
Q2 20241$1,014,420922,200
Q1 20241$2,0751,673,400
Q4 20231$1,8341,746,432
Q3 20231$4,436647,652
Q2 20231$10,054969,552

Related ACRS Institutional Insights:

ACRS Institutional Ownership and 13F Activity Q1 2026 | InsiderSet